Download PDF
Semin intervent Radiol 2022; 39(03): 292-303
DOI: 10.1055/s-0042-1753480
Review Article

Superior Vena Cava Syndrome: Etiologies, Manifestations, and Treatments

Keith B. Quencer
1   Dotter Interventional Institute, Oregon Health and Science University, Portland, Oregon
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Superior vena cava (SVC) obstruction, whether from benign or malignant causes, results in a variety of symptoms. It is a potential medical emergency when cerebral or laryngeal edema occurs. Endovascular therapy is the treatment of choice for patients in need of emergent relief of symptoms. This article will provide a review of SVC syndrome with a focus on endovascular treatment techniques.

Keywords

SVC syndrome - SVC stenting - stent migration - pericardial tamponade - interventional radiology


Publication History

Article published online:
31 August 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Büstgens FA, Loose R, Ficker JH, Wucherer M, Uder M, Adamus R. Stent implantation for superior vena cava syndrome of malignant cause. Röfo Fortschr Geb Röntgenstr Nuklearmed 2017; 189 (05) 423-430
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006; 85 (01) 37-42
    CrossrefPubMedGoogle Scholar
  • 3 Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev 2001; (04) CD001316
    PubMedGoogle Scholar
  • 4 Wan JF, Bezjak A. Superior vena cava syndrome. Hematol Oncol Clin North Am 2010; 24 (03) 501-513
    CrossrefPubMedGoogle Scholar
  • 5 Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 2011; 32 (04) 605-644
    CrossrefPubMedGoogle Scholar
  • 6 Picquet J, Blin V, Dussaussoy C, Jousset Y, Papon X, Enon B. Surgical reconstruction of the superior vena cava system: indications and results. Surgery 2009; 145 (01) 93-99
    CrossrefPubMedGoogle Scholar
  • 7 Schifferdecker B, Shaw JA, Piemonte TC, Eisenhauer AC. Nonmalignant superior vena cava syndrome: pathophysiology and management. Catheter Cardiovasc Interv 2005; 65 (03) 416-423
    CrossrefPubMedGoogle Scholar
  • 8 Caers J, Fontaine C, Vinh-Hung V. et al. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 2005; 13 (05) 325-331
    CrossrefPubMedGoogle Scholar
  • 9 Seo M, Shin WJ, Jun IG. Central venous catheter-related superior vena cava syndrome following renal transplantation - a case report. Korean J Anesthesiol 2012; 63 (06) 550-554
    CrossrefPubMedGoogle Scholar
  • 10 Deshwal H, Ghosh S, Magruder K, Bartholomew JR, Montgomery J, Mehta AC. A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis. Vasc Med 2020; 25 (02) 174-183
    CrossrefPubMedGoogle Scholar
  • 11 McIntire FT, Sykes Jr EM. Obstruction of the superior vena cava; a review of the literature and report of two personal cases. Ann Intern Med 1949; 30 (05) 925-960
    CrossrefPubMedGoogle Scholar
  • 12 Bayer O, Schummer C, Richter K, Fröber R, Schummer W. Implication of the anatomy of the pericardial reflection on positioning of central venous catheters. J Cardiothorac Vasc Anesth 2006; 20 (06) 777-780
    CrossrefPubMedGoogle Scholar
  • 13 Kim HJ, Kim HS, Chung SH. CT diagnosis of superior vena cava syndrome: importance of collateral vessels. AJR Am J Roentgenol 1993; 161 (03) 539-542
    CrossrefPubMedGoogle Scholar
  • 14 Stanford W, Jolles H, Ell S, Chiu LC. Superior vena cava obstruction: a venographic classification. AJR Am J Roentgenol 1987; 148 (02) 259-262
    CrossrefPubMedGoogle Scholar
  • 15 Eren S, Karaman A, Okur A. The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT. Eur J Radiol 2006; 59 (01) 93-103
    CrossrefPubMedGoogle Scholar
  • 16 Hussein FA, Mawla N, Befeler AS, Martin KJ, Lentine KL. Formation of downhill esophageal varices as a rare but serious complication of hemodialysis access: a case report and comprehensive literature review. Clin Exp Nephrol 2008; 12 (05) 407-415
    CrossrefPubMedGoogle Scholar
  • 17 Loudin M, Anderson S, Schlansky B. Bleeding ‘downhill’ esophageal varices associated with benign superior vena cava obstruction: case report and literature review. BMC Gastroenterol 2016; 16 (01) 134
    CrossrefPubMedGoogle Scholar
  • 18 Felson B, Lessure AP. “Downhill” varices of the esophagus. Dis Chest 1964; 46: 740-746
    PubMedGoogle Scholar
  • 19 Uceda PV, Peralta Rodriguez J, Vela H. et al. Management of superior vena cava occlusion causing bleeding “downhill” esophageal varices. J Endovasc Ther 2021; 28 (03) 469-473
    CrossrefPubMedGoogle Scholar
  • 20 Aloufi FF, Alabdulkarim FM, Alshahrani MA. The focal hepatic hot spot (“hot quadrate”) sign. Abdom Radiol (NY) 2017; 42 (04) 1289-1290
    CrossrefPubMedGoogle Scholar
  • 21 Ahmann FR. A reassessment of the clinical implications of the superior vena caval syndrome. J Clin Oncol 1984; 2 (08) 961-969
    CrossrefPubMedGoogle Scholar
  • 22 Yu JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome – a proposed classification system and algorithm for management. J Thorac Oncol 2008; 3 (08) 811-814
    CrossrefPubMedGoogle Scholar
  • 23 Gauden SJ. Superior vena cava syndrome induced by bronchogenic carcinoma: is this an oncological emergency?. Australas Radiol 1993; 37 (04) 363-366
    CrossrefPubMedGoogle Scholar
  • 24 Furui S, Sawada S, Kuramoto K. et al. Gianturco stent placement in malignant caval obstruction: analysis of factors for predicting the outcome. Radiology 1995; 195 (01) 147-152
    CrossrefPubMedGoogle Scholar
  • 25 Nicholson AA, Ettles DF, Arnold A, Greenstone M, Dyet JF. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol 1997; 8 (05) 781-788
    CrossrefPubMedGoogle Scholar
  • 26 Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol) 2002; 14 (05) 338-351
    CrossrefPubMedGoogle Scholar
  • 27 Goodman R. Superior vena cava syndrome. Clinical management. JAMA 1975; 231 (01) 58-61
    CrossrefPubMedGoogle Scholar
  • 28 Varricchio C. Clinical management of superior vena cava syndrome. Heart Lung 1985; 14 (04) 411-416
    PubMedGoogle Scholar
  • 29 Straka C, Ying J, Kong FM, Willey CD, Kaminski J, Kim DW. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus 2016; 5: 229
    CrossrefPubMedGoogle Scholar
  • 30 Armstrong BA, Perez CA, Simpson JR, Hederman MA. Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys 1987; 13 (04) 531-539
    CrossrefPubMedGoogle Scholar
  • 31 Weintraub NL, Jones WK, Manka D. Understanding radiation-induced vascular disease. J Am Coll Cardiol 2010; 55 (12) 1237-1239
    CrossrefPubMedGoogle Scholar
  • 32 Van Putten JW, Schlosser NJ, Vujaskovic Z, Leest AH, Groen HJ. Superior vena cava obstruction caused by radiation induced venous fibrosis. Thorax 2000; 55 (03) 245-246
    CrossrefPubMedGoogle Scholar
  • 33 Castonguay M, Rodrigues G, Vincent M, Malthaner RA, Guo LR. Chemoradiation-induced superior vena cava syndrome: a case report. Can Respir J 2008; 15 (08) 444-446
    CrossrefPubMedGoogle Scholar
  • 34 Charnsangavej C, Carrasco CH, Wallace S. et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology 1986; 161 (02) 295-298
    CrossrefPubMedGoogle Scholar
  • 35 Azizi AH, Shafi I, Zhao M. et al. Endovascular therapy for superior vena cava syndrome: a systematic review and meta-analysis. EClinicalMedicine 2021; 37: 100970
    CrossrefPubMedGoogle Scholar
  • 36 Rizvi AZ, Kalra M, Bjarnason H, Bower TC, Schleck C, Gloviczki P. Benign superior vena cava syndrome: stenting is now the first line of treatment. J Vasc Surg 2008; 47 (02) 372-380
    CrossrefPubMedGoogle Scholar
  • 37 Klop B, Scheffer MG, McFadden E, Bracke F, van Gelder B. Treatment of pacemaker-induced superior vena cava syndrome by balloon angioplasty and stenting. Neth Heart J 2011; 19 (01) 41-46
    CrossrefPubMedGoogle Scholar
  • 38 Lanciego C, Rodriguez M, Rodriguez A, Carbonell MA, García LG. Permanent pacemaker-induced superior vena cava syndrome: successful treatment by endovascular stent. Cardiovasc Intervent Radiol 2003; 26 (06) 576-579
    CrossrefPubMedGoogle Scholar
  • 39 Riley RF, Petersen SE, Ferguson JD, Bashir Y. Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice. Pacing Clin Electrophysiol 2010; 33 (04) 420-425
    CrossrefPubMedGoogle Scholar
  • 40 Guimaraes M, Schonholz C, Hannegan C, Anderson MB, Shi J, Selby Jr B. Radiofrequency wire for the recanalization of central vein occlusions that have failed conventional endovascular techniques. J Vasc Interv Radiol 2012; 23 (08) 1016-1021
    CrossrefPubMedGoogle Scholar
  • 41 Dinkel HP, Mettke B, Schmid F, Baumgartner I, Triller J, Do DD. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement?. J Endovasc Ther 2003; 10 (04) 788-797
    CrossrefPubMedGoogle Scholar
  • 42 Gwon DI, Ko GY, Kim JH, Shin JH, Yoon HK, Sung KB. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents. Radiology 2013; 266 (03) 979-987
    CrossrefPubMedGoogle Scholar
  • 43 Rösch J, Uchida BT, Hall LD. et al. Gianturco-Rösch expandable Z-stents in the treatment of superior vena cava syndrome. Cardiovasc Intervent Radiol 1992; 15 (05) 319-327
    CrossrefPubMedGoogle Scholar
  • 44 L McDevitt J, T Goldman D, J Bundy J, et al. Gianturco Z-stent placement for the treatment of chronic central venous occlusive disease: implantation of 208 stents in 137 symptomatic patients. Diagn Interv Radiol 2021; 27 (01) 72-78
    CrossrefPubMedGoogle Scholar
  • 45 Gaines PA, Belli AM, Anderson PB, McBride K, Hemingway AP. Superior vena caval obstruction managed by the Gianturco Z Stent. Clin Radiol 1994; 49 (03) 202-206 , discussion 207–208
    CrossrefPubMedGoogle Scholar
  • 46 Han TM, Bondarev S, Keller EJ, Vogelzang RL, Resnick SA. Efficacy of endovascular Z-configuration stenting for malignant versus nonmalignant caval obstruction. J Vasc Surg Venous Lymphat Disord 2020; 8 (06) 939-944
    CrossrefPubMedGoogle Scholar
  • 47 Lanciego C, Pangua C, Chacón JI. et al. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. AJR Am J Roentgenol 2009; 193 (02) 549-558
    CrossrefPubMedGoogle Scholar
  • 48 Hennequin LM, Fade O, Fays JG. et al. Superior vena cava stent placement: results with the wallstent endoprosthesis. Radiology 1995; 196 (02) 353-361
    CrossrefPubMedGoogle Scholar
  • 49 Verstandig AG, Bloom AI, Sasson T, Haviv YS, Rubinger D. Shortening and migration of wallstents after stenting of central venous stenoses in hemodialysis patients. Cardiovasc Intervent Radiol 2003; 26 (01) 58-64
    CrossrefPubMedGoogle Scholar
  • 50 Fagedet D, Thony F, Timsit JF. et al. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol 2013; 36 (01) 140-149
    CrossrefPubMedGoogle Scholar
  • 51 Da Ines D, Chabrot P, Motreff P. et al. Cardiac tamponade after malignant superior vena cava stenting: two case reports and brief review of the literature. Acta Radiol 2010; 51 (03) 256-259
    CrossrefPubMedGoogle Scholar
  • 52 Vijayvergiya R, Kanabar K, Kaushal S, Lal A, Krishnan S. Endovascular treatment of a migrated superior vena cava stent in the right atrium. J Invasive Cardiol 2020; 32 (06) E168-E169
    PubMedGoogle Scholar
  • 53 Taylor JD, Lehmann ED, Belli AM. et al. Strategies for the management of SVC stent migration into the right atrium. Cardiovasc Intervent Radiol 2007; 30 (05) 1003-1009
    CrossrefPubMedGoogle Scholar
  • 54 Srinathan S, McCafferty I, Wilson I. Radiological management of superior vena caval stent migration and infection. Cardiovasc Intervent Radiol 2005; 28 (01) 127-130
    CrossrefPubMedGoogle Scholar
  • 55 Okamoto D, Takeuchi Y, Arai Y. et al. Bridging stent placement through the superior vena cava to the inferior vena cava in a patient with malignant superior vena cava syndrome and an iodinated contrast material allergy. Jpn J Radiol 2014; 32 (08) 496-499
    CrossrefPubMedGoogle Scholar
  • 56 Haddad MM, Thompson SM, McPhail IR. et al. Is long-term anticoagulation required after stent placement for benign superior vena cava syndrome?. J Vasc Interv Radiol 2018; 29 (12) 1741-1747
    CrossrefPubMedGoogle Scholar
  • 57 Thony F, Fagedet D, Michoud M, Moro-Sibilot D, Ferretti GR, Rodière M. Anticoagulation is not mandatory after stenting for malignant superior vena cava syndrome. Cardiovasc Intervent Radiol 2014; 37 (05) 1403-1404
    CrossrefPubMedGoogle Scholar
  • 58 Uberoi R. Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Intervent Radiol 2006; 29 (03) 319-322
    CrossrefPubMedGoogle Scholar
  • 59 Leon D, Rao S, Huang S. et al. Literature review of percutaneous stenting for palliative treatment of malignant superior vena cava syndrome (SVCS). Acad Radiol 2021
    PubMedGoogle Scholar
  • 60 Majumdar S, Shoela R, Kim DJ. et al. Endovascular management of SVC syndrome due to fibrosing mediastinitis - a feasibility and safety analysis. Vasc Endovascular Surg 2018; 52 (03) 202-206
    CrossrefPubMedGoogle Scholar
  • 61 Kang CH, Yang SB, Lee WH. et al. Comparison of open-cell stent and closed-cell stent for treatment of central vein stenosis or occlusion in hemodialysis patients. Iran J Radiol 2016; 13 (04) e37994
    PubMedGoogle Scholar
  • 62 Smayra T, Otal P, Chabbert V. et al. Long-term results of endovascular stent placement in the superior caval venous system. Cardiovasc Intervent Radiol 2001; 24 (06) 388-394
    CrossrefPubMedGoogle Scholar
  • 63 Nguyen NP, Borok TL, Welsh J, Vinh-Hung V. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax 2009; 64 (02) 174-178
    CrossrefPubMedGoogle Scholar
  • 64 Sobrinho G, Aguiar P. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients. Arch Bronconeumol 2014; 50 (04) 135-140
    CrossrefPubMedGoogle Scholar
  • 65 Skovira V, Ahmed M, Genese TO. Superior vena cava syndrome in conjunction with pulmonary vasculature compromise: a case study and literature review. Am J Case Rep 2018; 19: 1237-1240
    CrossrefPubMedGoogle Scholar
  • 66 Kishi K, Sonomura T, Mitsuzane K. et al. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology 1993; 189 (02) 531-535
    CrossrefPubMedGoogle Scholar
  • 67 Slonim SM, Dake MD, Razavi MK. et al. Management of misplaced or migrated endovascular stents. J Vasc Interv Radiol 1999; 10 (07) 851-859
    CrossrefPubMedGoogle Scholar
  • 68 Haddad MM, Simmons B, McPhail IR. et al. Comparison of covered versus uncovered stents for benign superior vena cava (SVC) obstruction. Cardiovasc Intervent Radiol 2018; 41 (05) 712-717
    CrossrefPubMedGoogle Scholar
  • 69 Cho Y, Gwon DI, Ko GY. et al. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?. Korean J Radiol 2014; 15 (01) 87-94
    CrossrefPubMedGoogle Scholar